Which major deals marked 2018 M&A, a year during which the industry had high expectations for deal activity, given the anticipation of favorable tax breaks in the US? Explore what deals and companies showed the most activity, take a look at the year’s biggest deals and areas of interest, and understand the trends that 2018’s M&A deals may indicate for the future with this informative look at the market from In Vivo. Covered is a look at in-licensing, acquisitions, top deals by therapeutic area, and IPO and VP investment in various therapeutic areas.